Finland · Biotechnology startup
Finland · Tenboron
Tenboron is the developer of a boron neutron capture therapy intended to treat locally invasive malignant tumors.
Funding reportedLast round: Undisclosed round
What company datasets say Tenboron raised
Funding, as reported
Reported in all4.5Min the source's currency
Rounds2
Last roundUndisclosed round
Last round dateMay 2019
Investors listed1
On a portfolio page
Investors who name them
Each firm lists Tenboron on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biotechnology in Finland
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Tenboron in front of investors. Or tell us what we have wrong.